Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
David Schnur Associates is a private medical device services company focused on device design, development, materials sourcing, technical sales, and manufacturing partner access for the medical technology industry. Rather than operating as a therapeutics developer, the company acts as a single-source commercial and technical interface connecting customers with a network of specialized component, materials, coating, tubing, metals, and device manufacturing partners. Its offerings span concept and product development support, supply-chain refinement, and access to ready-to-ship medical materials and outsourced manufacturing capabilities. The business appears oriented toward interventional and other medical device developers, including support for catheter, implant, coating, and related device applications. DSA is best characterized as a medtech commercialization and partner-network platform rather than a biotech or pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on David Schnur Associates.